Cargando…

Application of a novel prognostic invasive lesion index in ductal carcinoma in situ with minimal invasion of the breast

Multiple invasive foci has been shown to increase the risk of lymph node metastasis (LNM) in early breast cancer, but its prognostic implication remains unknown. We aimed to identify the prognostic value of the number of invasive foci in ductal carcinoma in situ with minimal invasion of the breast (...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Xiaofang, Ye, Feng, Li, Mei, Yu, Ping, Xiao, Xiangsheng, Tang, Hailin, Xie, Xiaoming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673919/ https://www.ncbi.nlm.nih.gov/pubmed/28980458 http://dx.doi.org/10.1002/cam4.1175

Ejemplares similares

Identification of aberrant gene expression during breast ductal carcinoma in situ progression to invasive ductal carcinoma
por: Song, Guiqin, et al.
Publicado: (2019)

Risk factors and their diagnostic values for ocular metastases in invasive ductal carcinoma
por: Liang, Rong‐Bin, et al.
Publicado: (2020)

Hormone Receptor Subtype in Ductal Carcinoma in Situ: Prognostic and Predictive Roles of the Progesterone Receptor
por: Hwang, Ki‐Tae, et al.
Publicado: (2021)

Predictors for local invasive recurrence of ductal carcinoma in situ of the breast: a meta-analysis
por: Zhang, Xining, et al.
Publicado: (2016)

Prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in breast: A meta-analysis of PSM studies
por: Ye, Feng, et al.
Publicado: (2020)

Tamoxifen Initiation After Ductal Carcinoma In Situ
por: Nichols, Hazel B., et al.
Publicado: (2016)

Basal cytokeratin as a potential marker of low risk of invasion in ductal carcinoma in situ
por: Aguiar, Fernando N., et al.
Publicado: (2013)

Breast‐conserving therapy shows better prognosis in mucinous breast carcinoma compared with mastectomy: A SEER population‐based study
por: Yu, Ping, et al.
Publicado: (2020)

Characteristics, prognosis, risk factors, and management of recently diagnosed ductal carcinoma in situ with microinvasion
por: Li, Chunyan, et al.
Publicado: (2021)

Breast cancer stromal clotting activation (Tissue Factor and thrombin): A pre‐invasive phenomena that is prognostic in invasion
por: Shaker, Hudhaifah, et al.
Publicado: (2020)

Axillary evaluation is not warranted in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy
por: Si, Jing, et al.
Publicado: (2019)

Does concomitant ductal carcinoma in situ affect the clinical outcome in breast cancer patients with invasive ductal carcinoma: An Asian perspective
por: Lee, Wai Peng, et al.
Publicado: (2022)

Trends and clinicopathological predictors of axillary evaluation in ductal carcinoma in situ patients treated with breast‐conserving therapy
por: Huang, Nai‐si, et al.
Publicado: (2017)

Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
por: Wei, Zhang, et al.
Publicado: (2012)

Lobular carcinoma in situ of the breast – correlation between minimally invasive biopsy and final pathology
por: Szynglarewicz, Bartłomiej, et al.
Publicado: (2016)

Minimally Invasive Video-Assisted versus Minimally Invasive Nonendoscopic Thyroidectomy
por: Fík, Zdeněk, et al.
Publicado: (2014)

Diallyl Trisulfide Induces Apoptosis in Breast Ductal Carcinoma In Situ Derived and Minimally Invasive Breast Cancer Cells
por: Stan, Silvia D., et al.
Publicado: (2022)

Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer
por: Kim, Shinn Young, et al.
Publicado: (2015)

Invasive micropapillary carcinoma of the breast has a better long‐term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case–control analysis
por: Chen, Hongliang, et al.
Publicado: (2017)

Development and validation of a prognostic nomogram based on the log odds of positive lymph nodes (LODDS) for breast cancer
por: Wen, Jiahuai, et al.
Publicado: (2016)

Prognostic significance of tumor size for primary invasive cutaneous melanoma: A population‐based study, 2004‐2016
por: Ma, Qiuying, et al.
Publicado: (2020)

Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinoma
por: Rebbeck, Clare A., et al.
Publicado: (2022)

An Updated Nomogram for Predicting Invasiveness in Preoperative Ductal Carcinoma In Situ of the Breast
por: Kim, Sanghwa, et al.
Publicado: (2019)

Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ
por: Takada, Koji, et al.
Publicado: (2020)

Comparison of clinicopathological characteristics and prognosis among patients with pure invasive ductal carcinoma, invasive ductal carcinoma coexisted with invasive micropapillary carcinoma, and invasive ductal carcinoma coexisted with ductal carcinoma in situ: A retrospective cohort study
por: Guan, Xin, et al.
Publicado: (2020)

Minimally invasive surgery vs laparotomy for early stage cervical cancer: A propensity score‐matched cohort study
por: Dai, Danian, et al.
Publicado: (2020)

Serum p53 autoantibodies in patients with minimal lesions of ductal carcinoma in situ of the breast
por: Regele, S, et al.
Publicado: (1999)

Prognostic and staging implications of mandibular canal invasion in lower gingival squamous cell carcinoma
por: Okura, Masaya, et al.
Publicado: (2016)

Prognostic impact of extratumoral perineural invasion in patients with oral cavity squamous cell carcinoma
por: Lee, Li‐Yu, et al.
Publicado: (2019)

Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004–2013
por: van der Horst, Judith, et al.
Publicado: (2017)

Genetic alterations in ductal carcinoma in situ and invasive carcinoma of the breast
por: Robanus-Maandag, E, et al.
Publicado: (2000)

The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ
por: Gilleard, Onur, et al.
Publicado: (2008)

Outcomes for Atypical Tumor Recurrences Following Minimally Invasive Kidney Cancer Operations
por: Russo, Paul, et al.
Publicado: (2022)

Real‐world prognostic factors for survival among treated patients with metastatic pancreatic ductal adenocarcinoma
por: Yu, Kenneth H., et al.
Publicado: (2021)

Prognostic value of ductal carcinoma in situ component in invasive ductal carcinoma of the breast: a Surveillance, Epidemiology, and End Results database analysis
por: Wu, San-Gang, et al.
Publicado: (2018)

Effect of Chin‐down‐plus‐larynx‐tightening maneuver on swallowing function after minimally invasive esophagectomy: A randomized controlled trail
por: Yang, Funa, et al.
Publicado: (2020)

Prognostic value of γ‐glutamyltransferase‐to‐albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery
por: Li, Shuo, et al.
Publicado: (2019)

Investigation of Plasma cell‐free cancer genome chromosomal instability as a tool for targeted minimally invasive biomarkers for primary liver cancer diagnoses
por: Feng, Shuang, et al.
Publicado: (2020)

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer
por: Tamimi, Rulla M, et al.
Publicado: (2008)

SOX11 promotes invasive growth and ductal carcinoma in situ progression
por: Oliemuller, Erik, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_69n3slg19ed2uktm6laaekcmee